Terms: = Lung cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
494 results:
1. The β2-adrenergic receptor associates with cxcr4 multimers in human cancer cells.
Liang J; Seghiri M; Singh PK; Seo HG; Lee JY; Jo Y; Song YB; Park C; Zalicki P; Jeong JY; Huh WK; Caculitan NG; Smith AW
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2304897121. PubMed ID: 38547061
[TBL] [Abstract] [Full Text] [Related]
2. Targeting the CXCL12/cxcr4 pathway to reduce radiation treatment side effects.
Chaudary N; Hill RP; Milosevic M
Radiother Oncol; 2024 May; 194():110194. PubMed ID: 38447871
[TBL] [Abstract] [Full Text] [Related]
3. CD34
Perrone C; Bozzano F; Dal Bello MG; Del Zotto G; Antonini F; Munari E; Maggi E; Moretta F; Farshchi AH; Pariscenti G; Tagliamento M; Genova C; Moretta L; De Maria A
Front Immunol; 2024; 15():1332781. PubMed ID: 38390333
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract] [Full Text] [Related]
5. Anti-collagenase, Anti-elastase, Anti-urease, and Anti-cancer Potentials of Isokaempferide as Natural Compound: In vitro and in silico Study.
Yin Q; Zhang H; Huang T; Liu B; Negm S; El-Kott AF
J Oleo Sci; 2024; 73(2):187-199. PubMed ID: 38311409
[TBL] [Abstract] [Full Text] [Related]
6. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.
Liu R; Zhu G; Sun Y; Li M; Hu Z; Cao P; Li X; Song Z; Chen J
Front Immunol; 2023; 14():1304529. PubMed ID: 38204755
[TBL] [Abstract] [Full Text] [Related]
7. cxcr4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
8. Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting cxcr4.
Pei J; Cheng K; Liu T; Gao M; Wang S; Xu S; Guo Y; Ma L; Li W; Wang B; Yu J; Liu J
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1109-1120. PubMed ID: 38030744
[TBL] [Abstract] [Full Text] [Related]
9. Chemokine Receptor cxcr4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine cancers.
Fath MA; Liu D; Ewald JT; Robles-Planells C; Tomanek-Chalkley AM; Graves SA; Howe JR; O'Dorisio TM; Rastogi P; Bellizzi AM; O'Dorisio MS; Menda Y; Spitz DR
Radiat Res; 2024 Jan; 201(1):35-47. PubMed ID: 37989124
[TBL] [Abstract] [Full Text] [Related]
10. Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling.
Petraroia I; Ghidotti P; Bertolini G; Pontis F; Roz L; Balsamo M; Suatoni P; Pastorino U; Ferretti AM; Sozzi G; Fortunato O
Cell Death Dis; 2023 Oct; 14(10):681. PubMed ID: 37838700
[TBL] [Abstract] [Full Text] [Related]
11. Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature.
Zhang P; Zhang X; Cui Y; Gong Z; Wang W; Lin S
Front Immunol; 2023; 14():1244144. PubMed ID: 37671160
[TBL] [Abstract] [Full Text] [Related]
12. [Exploration of the Perturbation of PKIG in lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
[TBL] [Abstract] [Full Text] [Related]
13. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
[TBL] [Abstract] [Full Text] [Related]
14. Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients.
Cambier S; Beretta F; Pörtner N; Metzemaekers M; de Carvalho AC; Martens E; Kaes J; Aelbrecht C; Jacobs C; Van Mol P; Wauters E; Meersseman P; Hermans G; Marques RE; Vanaudenaerde B; Vos R; Wauters J; Gouwy M; Proost P
Cell Mol Life Sci; 2023 Jul; 80(8):234. PubMed ID: 37505242
[TBL] [Abstract] [Full Text] [Related]
15. CXCL12-cxcr4/CXCR7 Axis in cancer: from Mechanisms to Clinical Applications.
Yang Y; Li J; Lei W; Wang H; Ni Y; Liu Y; Yan H; Tian Y; Wang Z; Yang Z; Yang S; Yang Y; Wang Q
Int J Biol Sci; 2023; 19(11):3341-3359. PubMed ID: 37497001
[TBL] [Abstract] [Full Text] [Related]
16. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
Lu G; Wang X; Cheng M; Wang S; Ma K
Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
[TBL] [Abstract] [Full Text] [Related]
17. cxcr4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors.
Yu J; Zhou X; Shen L
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375261
[TBL] [Abstract] [Full Text] [Related]
18. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor.
Sawant M; Wilson A; Sridaran D; Mahajan K; O'Conor CJ; Hagemann IS; Luo J; Weimholt C; Li T; Roa JC; Pandey A; Wu X; Mahajan NP
Oncogene; 2023 Jul; 42(29):2263-2277. PubMed ID: 37330596
[TBL] [Abstract] [Full Text] [Related]
20. cxcr4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/cxcr4 signaling axis in preclinical breast cancer model.
Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
[TBL] [Abstract] [Full Text] [Related]
[Next]
